Literature DB >> 12759425

Drug-inducible, dendritic cell-based genetic immunization.

Laura Timares1, Karim Mahmoud Safer, Baoxi Qu, Akira Takashima, Stephen Albert Johnston.   

Abstract

Determining the mechanism of Ag loading of Langerhans cells (LC) for genetic immunization (GI) is complicated by the inability to distinguish between the response generated by direct transfection of LC from that due to exogenous uptake. To unravel this mechanism, we examined the impact of gene gun treatment on LC with respect to their activation and migration from skin, transgene expression, and ability to initiate humoral and cellular immune responses upon transfer to naive mice. To assess responses generated by direct LC transfection, an RU486-inducible expression system was used as a GI vector. In vitro skin organ cultures were developed from gene gun immunized mouse ear specimens to obtain LC. Gene gun treatment markedly augmented (3-fold) LC migration from ear skin, and these LC expressed the transgene at RNA and protein levels. Transfer of 2 x 10(5) migratory cells resulted in identical cellular responses to, but 10-fold lower humoral responses than, standard GI. Using an RU486-inducible system, we were able to measure responses generated by directly transfected LC. Our results indicate that direct transfection is a predominant pathway for LC Ag loading. The ability to regulate transgene expression with inducible DC-based vaccines demonstrates a new level of immunological control.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759425     DOI: 10.4049/jimmunol.170.11.5483

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  CD4 T cell-induced, bid-dependent apoptosis of cutaneous dendritic cells regulates T cell expansion and immune responses.

Authors:  Sanjay Pradhan; Joseph Genebriera; Warren L Denning; Kumar Felix; Craig A Elmets; Laura Timares
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

2.  Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.

Authors:  Stephan Sudowe; Sabine Dominitzki; Evelyn Montermann; Matthias Bros; Stephan Grabbe; Angelika B Reske-Kunz
Journal:  Immunology       Date:  2008-09-17       Impact factor: 7.397

3.  Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour.

Authors:  Keng Wooi Ng; Marc Pearton; Sion Coulman; Alexander Anstey; Christopher Gateley; Anthony Morrissey; Christopher Allender; James Birchall
Journal:  Vaccine       Date:  2009-08-11       Impact factor: 3.641

Review 4.  Langerhans Cells Orchestrate TFH-Dependent Humoral Immunity.

Authors:  Trupti Vardam; Niroshana Anandasabapathy
Journal:  J Invest Dermatol       Date:  2017-09       Impact factor: 8.551

5.  Shikonin enhances efficacy of a gene-based cancer vaccine via induction of RANTES.

Authors:  Hui-Ming Chen; Pi-Hsueh Wang; Kandan Aravindaram; Yun-Hsiang Chen; Hsiu-Hui Yu; Wen-Chin Yang; Ning-Sun Yang
Journal:  J Biomed Sci       Date:  2012-04-12       Impact factor: 8.410

6.  Novel immune-modulator identified by a rapid, functional screen of the parapoxvirus ovis (Orf virus) genome.

Authors:  Michael J McGuire; Stephen A Johnston; Kathryn F Sykes
Journal:  Proteome Sci       Date:  2012-01-13       Impact factor: 2.480

7.  Mechanisms of immunization against cancer using chimeric antigens.

Authors:  Manuel E Engelhorn; José A Guevara-Patiño; Taha Merghoub; Cailian Liu; Cristina R Ferrone; Gabriele A Rizzuto; Daniel H Cymerman; David N Posnett; Alan N Houghton; Jedd D Wolchok
Journal:  Mol Ther       Date:  2008-02-26       Impact factor: 12.910

8.  Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor.

Authors:  Alessia Lamolinara; Lorenzo Stramucci; Albana Hysi; Manuela Iezzi; Cristina Marchini; Marianna Mariotti; Augusto Amici; Claudia Curcio
Journal:  J Immunol Res       Date:  2015-07-13       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.